Neurofibromatosis type 1 (NF1) is a genetic condition that, among its many features, comes with an increased risk of certain gliomas. If you or your child has NF1, understanding this connection helps you partner with your care team on appropriate monitoring — without living in constant fear.
What NF1 is NF1 is a genetic disorder caused by changes in the NF1 gene, which normally helps control cell growth. It affects many parts of the body and can cause skin findings (café-au-lait spots, freckling), benign nerve tumors (neurofibromas), bone and eye findings, and learning differences. It also predisposes to certain tumors, including specific gliomas.
The glioma connection People with NF1 have a higher risk of developing low-grade gliomas, most characteristically optic pathway gliomas (tumors of the visual system) in early childhood. NF1-associated gliomas are typically low-grade and often indolent — many never cause symptoms or require treatment. Less commonly, other low-grade gliomas of the brain can occur, and the risk of higher-grade tumors, while present, is much lower.
Why monitoring matters Because of the risk of optic pathway gliomas, children with NF1 are usually followed with regular eye examinations in early childhood — checking vision and the optic nerves — so that any tumor affecting vision can be caught and addressed early. Routine brain MRI screening of children with NF1 who have no symptoms is generally not recommended; instead, imaging is guided by symptoms or eye findings. Your care team will explain the monitoring schedule appropriate for your situation.
How NF1-associated gliomas are treated Many require only observation, since they're often stable. When treatment is needed (for growth or threatened vision), chemotherapy and targeted therapies are typically used rather than surgery, and radiation is generally avoided in children with NF1 — partly because of developing-brain concerns and partly because NF1 itself can increase sensitivity to radiation's long-term effects. Research into MEK-pathway targeted drugs has been especially relevant for NF1-related tumors.
Living with the risk Most children with NF1 do not develop a symptomatic brain tumor, and those who do most often have low-grade, manageable disease. The goal is appropriate, not excessive, monitoring — staying alert to vision and neurological changes while letting children live full lives. NF1 is best managed by a team familiar with the condition, who can coordinate the eye, neurological, developmental, and other aspects of care.
If NF1 runs in your family, genetic counseling can help you understand inheritance and what monitoring makes sense for each person.